Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota
母亲肥胖对后代乳腺癌的影响:肠道微生物群的作用
基本信息
- 批准号:10734892
- 负责人:
- 金额:$ 35.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAgonistAir PollutionAllograftingAmerican IndiansAntibioticsBacteriaBiologicalBiological SciencesBirthBlack raceBreast Cancer CellBreast Cancer ModelBreast Cancer Risk FactorC57BL/6 MouseCD8-Positive T-LymphocytesCRISPR/Cas technologyCell physiologyCellsChildClinicalClostridiaceaeCognitiveCommunitiesConsumptionCrimeDaughterDiabetes MellitusDietary FiberDietary InterventionDiscipline of NursingEmotionalEndocrinologyEtiologyExposure toFFAR2 geneFFAR3 geneFemaleFemale of child bearing ageFetal TissuesFiberFunctional disorderGenerationsGoalsGrowthHumanImmuneImmunityImpairmentIncidenceIndividualInflammationInflammatoryInterventionIntervention StudiesInulinKnock-outKnockout MiceLifeLinkLong-Term EffectsMammary NeoplasmsMammary TumorigenesisMass Spectrum AnalysisMeasuresMediatingMetabolismMicrobeMinnesotaMouse Mammary Tumor VirusMusNot Hispanic or LatinoObesityObesity EpidemicOrganOutcomePlayPredispositionPregnancyPregnant WomenPrevention strategyPrevotellaProbioticsProductionPublic HealthReportingRiskRoleShotgunsSignal TransductionTestingTissuesTransplantationTumor-infiltrating immune cellsVolatile Fatty AcidsWhole BloodWomananti-tumor immune responsecell typeclinical translationdiet-induced obesitydietarydietary controldrinking watereffective interventionfecal microbiotafecal transplantationgut bacteriagut dysbiosisgut microbesgut microbiotahealth disparityimmune cell infiltrateimmune functioninflammatory markerlow socioeconomic statusmalignant breast neoplasmmammarymaternal obesitymetagenomic sequencingmitochondrial metabolismmortalityobese mothersobesity in pregnancyoffspringpolyoma middle tumor antigenpregnantpreventprogramsreceptorstem cell differentiationwestern diet
项目摘要
In Minnesota, American Indian (34.1%) and non-Hispanic Black (33.4%) women are over twice as likely to be
obese during pregnancy than non-Hispanic White women of whom 16.6% are obese during pregnancy. This
high incidence reflects the causes of maternal obesity such as low socioeconomic status, high crime rate, and
excess exposure to air pollution. Maternal obesity has widespread adverse effects on the offspring including
increasing their risk of dying from breast cancer. Maternal obesity also permanently disrupts the mutually
beneficial interaction between the offspring and offspring’s gut microbiota, causing gut dysbiosis. Gut dysbiosis
in the offspring is characterized by a reduction in the gut bacteria that produce fecal short-chain fatty acids
(SCFA). SCFAs play pivotal roles in maintaining healthy immune functions, cellular metabolism, and other critical
functions. These compounds act mostly through their receptors GPR43 and GPR41, which are expressed in
immune cells and multiple other cell types. Here, we will test the central hypothesis that the composition of
commensal gut microbes in the offspring of obese dams is causally responsible for an offspring’s increased
susceptibility to mammary tumorigenesis, an effect that likely also reflects altered immunity. We will test this
causal link by performing fecal microbiota transfers (FMTs). The role of GPR43 and GPR41 in mediating the
impact of maternal obesity on offspring will be tested using CRISPR/Cas9 knockout mice. The potential for
clinical translation of our findings will be established by supplementing obese pregnant dams with a commercially
available probiotic mix of SCFA-producing gut bacteria and dietary fiber that increases SCFA production. Such
a combination has been earlier found to be most effective in reversing loss of critical microbes of healthy gut
microbiota from individuals who have consumed an unhealthy Western diet for multiple generations. We will use
allografted E0771 and Py230 mammary tumor models and MMTV-PyMT mice developing mammary tumors at
about age 3 months. Shotgun metagenome sequencing and mass spectrometry will be applied to study gut
microbiota and their metabolites, respectively. Changes in immune cell infiltration and activity will be measured
in multiple tissues and compared with the expression of GPR43 and GPR41 in immune cells. Our studies could
lead to effective and safe prevention strategies against breast cancer and its growth in the daughters of obese
mothers, and be particularly beneficial for communities suffering from health disparities.
在明尼苏达州,美洲印第安人(34.1%)和非西班牙裔黑人(33.4%)妇女的可能性超过两倍
怀孕期间的肥胖比非西班牙裔白人妇女,其中16.6%的怀孕期间肥胖。这
高事件反映了孕产妇肥胖的原因,例如社会经济状况低,犯罪率高和
过度暴露于空气污染。孕产妇肥胖对后代有不利影响,包括
增加他们因乳腺癌而死的风险。孕产妇肥胖也永久破坏相互破坏
后代和后代的肠道微生物群之间的有益相互作用,导致肠道营养不良。
在后代中的特征是减少产生粪便短链脂肪酸的肠道细菌
(SCFA)。 SCFA在维持健康的免疫功能,细胞代谢和其他关键方面发挥关键作用
功能。这些化合物主要通过其受体GPR43和GPR41作用
免疫细胞和其他多种细胞类型。在这里,我们将测试中心假设,即
肥胖大坝后代的共生肠道微生物有时是造成后代增加的原因
对乳腺肿瘤发生的敏感性,这种作用也可能反映出免疫力改变。我们将测试这个
通过进行粪便微生物群转移(FMT)来因果关系。 GPR43和GPR41在中介
孕产妇肥胖对后代的影响将使用CRISPR/CAS9敲除小鼠进行测试。潜力
我们的发现的临床翻译将通过用商业上补充肥胖的孕妇大坝来确定
可用的产生SCFA的肠道细菌和饮食纤维的可用益生菌混合物,可增加SCFA的产生。这样的
早些时候发现一种组合在逆转健康肠道临界微生物的损失方面最有效
从几代人食用不健康的西方饮食的人的微生物群。我们将使用
同种异体移植的E0771和PY230乳腺肿瘤模型以及MMTV-PYMT小鼠在乳腺肿瘤上发育于
大约3个月大。 shot弹枪元基因组测序和质谱法将用于研究肠道
微生物群及其代谢产物。将测量免疫细胞浸润和活性的变化
在多个时序中,与免疫细胞中GPR43和GPR41的表达进行了比较。我们的研究可以
导致针对乳腺癌的有效和安全的预防策略及其在肥胖女儿中的成长
母亲,对患有健康差异的社区特别有益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEENA A. HILAKIVI-CLARKE其他文献
LEENA A. HILAKIVI-CLARKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEENA A. HILAKIVI-CLARKE', 18)}}的其他基金
Improving response to immunotherapy by genistein and antiestrogens
改善金雀异黄素和抗雌激素免疫疗法的反应
- 批准号:
10112524 - 财政年份:2021
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8543663 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8706830 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8321741 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Early Life Estrogenicity and Mammary Cancer Risk
生命早期雌激素和乳腺癌风险
- 批准号:
8180999 - 财政年份:2010
- 资助金额:
$ 35.46万 - 项目类别:
Genome wide methylation arrays for detecting markers of increased susceptibility
用于检测易感性增加标记物的全基因组甲基化阵列
- 批准号:
7934998 - 财政年份:2009
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors
子宫内饮食接触内分泌干扰物
- 批准号:
7192451 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors and l*
在子宫内饮食中接触内分泌干扰物和 l*
- 批准号:
7060414 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors
子宫内饮食接触内分泌干扰物
- 批准号:
6940954 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
Timing of dietary exposure and breast cancer risk
饮食暴露时间与乳腺癌风险
- 批准号:
6802869 - 财政年份:2003
- 资助金额:
$ 35.46万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 35.46万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别: